Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

ACR Releases New Position Statements on Site of Service & Compounding

  |  

Mary Beth Nierengarten is a freelance medical journalist based in Minneapolis.

Resources

ADVERTISEMENT
SCROLL TO CONTINUE
  1. American College of Rheumatology Position Statement. Patient Safety and Site of Service for Biologics. http://www.rheumatology.org/Portals/0/Files/Biologics-Patient-Safety-and-site-of-Service.pdf.
  2. American College of Rheumatology Position Statement (Draft). Compounding of Pharmacologic Agents. http://www.rheumatology.org/Portals/0/Files/ACR-Position-Statement-Compounding-Pharmacologic-Agents.pdf.

Related Articles

    New Compounding Regulations could Adversely Affect Rheumatologists, Patients

    On July 28, 2018, the USP will publish preliminary updates to existing drug compounding standards that could affect whether rheumatologists maintain the ability to mix, combine or otherwise customize medications in office for individual patient use. The ACR, in concert with the American Medical Association (AMA) and others, is working to help ensure rheumatologists can…

    The ACR Takes a Stand: How Position Statements Are Created

    Through the development of position statements that lay out the ACR’s official stance on issues related to the management of rheumatic and musculoskeletal conditions, the Committee on Rheumatologic Care helps outline policies that affect the practice of rheumatology and the wellbeing and care of patients.